StockSelector.com
  Research, Select, & Monitor Saturday, February 24, 2018 4:42:20 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
BioMarin Pharmaceutical, Inc.$83.05($.95)(1.13%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

BioMarin Pharmaceutical, Inc. has an overall rank of 2722 out of 5959 stocks based on 6 positive rankings and 3 negative rankings.

Positive Rankings
PEGValue
BioMarin Pharmaceutical has a PEG Value of $352.26. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 324.15% in the next year. Among companies with a PEG Value above the current stock price, BioMarin Pharmaceutical is ranked 140.
SSValue
The StockSelector Value for BioMarin Pharmaceutical is $692.21. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, BioMarin Pharmaceutical is ranked 155.
Target Prices
The average analysts' target price is $113.00 for BioMarin Pharmaceutical using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, BioMarin Pharmaceutical is ranked 331.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, BioMarin Pharmaceutical is ranked 594.
Low Put/Call
BioMarin Pharmaceutical has a low Put/Call ratio of 0.63 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, BioMarin Pharmaceutical is ranked 1149.
10 Day Gain
BioMarin Pharmaceutical rank is 2937
Negative Rankings
Down EPS Surprise
BioMarin Pharmaceutical missed the consensus earnings estimate when it last reported quarterly earnings.
High vPut/Call
BioMarin Pharmaceutical has a high Put/Call ratio of 1.30 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, BioMarin Pharmaceutical is ranked 635.
90 Day Loss
BioMarin Pharmaceutical rank is 974







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.